We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
Cap. Flow
-$1.96B
Cap. Flow %
-1.67%
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101

Top Sells

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$607M
2
AAPL icon
Apple
AAPL
+$186M
3
MSFT icon
Microsoft
MSFT
+$139M
4
META icon
Meta Platforms (Facebook)
META
+$89.6M
5
NVDA icon
NVIDIA
NVDA
+$74.4M

Sector Composition

Rank Sector Weight
1 Technology 30.6%
2 Financials 12.67%
3 Consumer Discretionary 10.32%
4 Industrials 10.12%
5 Healthcare 9.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLPT icon
2701
ClearPoint Neuro
CLPT
$423M
$287K ﹤0.01%
31,504
+60
+0.2% +$758
PKOH icon
2702
Park-Ohio Holdings
PKOH
$554M
$286K ﹤0.01%
11,886
-97
-0.8% -$2.38K
RXST icon
2703
RxSight
RXST
$215M
$284K ﹤0.01%
46,175
+2,305
+5% +$19.1K
VOXR
2704
Vox Royalty Corp
VOXR
$301M
$284K ﹤0.01%
54,264
-2,970
-5% -$15.9K
FVR
2705
FrontView REIT
FVR
$494M
$284K ﹤0.01%
18,332
+693
+4% +$11.2K
REFI
2706
Chicago Atlantic Real Estate Finance
REFI
$258M
$283K ﹤0.01%
25,014
+1,610
+7% +$19.6K
LMNR icon
2707
Limoneira
LMNR
$237M
$283K ﹤0.01%
21,086
+141
+0.7% +$1.96K
ACRS icon
2708
Aclaris Therapeutics
ACRS
$730M
$283K ﹤0.01%
75,401
+3,597
+5% +$12.1K
NEXN
2709
Nexxen International
NEXN
$547M
$282K ﹤0.01%
43,327
-3,538
-8% -$22.6K
EOLS icon
2710
Evolus
EOLS
$394M
$282K ﹤0.01%
68,726
-1,323
-2% -$6.41K
LRMR icon
2711
Larimar Therapeutics
LRMR
$416M
$282K ﹤0.01%
62,685
-880
-1% -$3.52K
WOOF icon
2712
Petco
WOOF
$745M
$281K ﹤0.01%
101,241
-1,752
-2% -$4.85K
BH icon
2713
Biglari Holdings Class B
BH
$1.2B
$281K ﹤0.01%
852
+2
+0.2% +$748
NGNE icon
2714
Neurogene
NGNE
$696M
$280K ﹤0.01%
13,892
+509
+4% +$9.86K
OVLY icon
2715
Oak Valley Bancorp
OVLY
$274M
$280K ﹤0.01%
8,621
+15
+0.2% +$481
TRI icon
2716
Thomson Reuters
TRI
$39.4B
$279K ﹤0.01%
3,049
-106
-3% -$11.2K
CMTG icon
2717
Claros Mortgage Trust
CMTG
$306M
$278K ﹤0.01%
116,868
-3,390
-3% -$8.78K
NPB
2718
Northpointe Bancshares
NPB
$594M
$275K ﹤0.01%
15,955
+2,846
+22% +$50.1K
IWN icon
2719
iShares Russell 2000 Value ETF
IWN
$14.4B
$275K ﹤0.01%
1,452
-933
-39% -$181K
ASLE icon
2720
AerSale
ASLE
$292M
$274K ﹤0.01%
44,084
+1,616
+4% +$11.5K
SIGA icon
2721
SIGA Technologies
SIGA
$223M
$274K ﹤0.01%
51,142
-2,493
-5% -$15.5K
ULCC icon
2722
Frontier Group Holdings
ULCC
$1.34B
$272K ﹤0.01%
77,121
-26,644
-26% -$122K
RBBN icon
2723
Ribbon Communications
RBBN
$354M
$272K ﹤0.01%
128,405
+118
+0.1% +$282
EVMN
2724
Evommune Inc
EVMN
$409M
$272K ﹤0.01%
+11,821
New +$267K
HYLN icon
2725
Hyliion Holdings
HYLN
$663M
$271K ﹤0.01%
154,246
-8,164
-5% -$16.4K

Similar funds

RhumbLine Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
  • RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
  • RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
  • RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
  • RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
  • RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.